Elite Pharmaceuticals Inc
ELTP- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001053369
In the last 90 days, Elite Pharmaceuticals Inc insiders filed 1 open-market purchase and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $365 in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Elite Pharmaceuticals Inc changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 1 | 3 | +2 |
| Shares | 200.0K | 814.6K | +614.6K (+307.3%) |
| Value | $9.00K | $28.0K | +$19.0K (+211.1%) |
New holders (2)
Institutions that held Elite Pharmaceuticals Inc at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Blackston Financial Advisory Group, LLC | 532,605 | $18.0K | 0.01% |
| Fisher Asset Management, LLC | 82,000 | $3.00K | 0.00% |
Sold out (0)
Institutions that held Elite Pharmaceuticals Inc at the end of Q3 2021 and filed for Q4 2021 without it.
None.